Back to companies

Damora Therapeutics, Inc.

DMRAUSNASDAQPharmaceuticals & Healthcare

Damora Therapeutics, Inc.

Revenue
—
FY2025
Operating income
-$210.9mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API